Peroxisome Dysfunction and Steatotic Liver Disease.

Area of Science:

• Cellular Biology
• Metabolic Disorders
• Hepatology

Background:

• Peroxisomes are vital organelles for lipid metabolism and reactive oxygen species detoxification.
• Peroxisomal disorders result from genetic defects, causing diverse clinical manifestations, including liver issues.
• Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing global health concern.

Purpose of the Study:

• To investigate the potential role of peroxisomal dysfunction in the pathogenesis of MASLD.
• To review current understanding of peroxisomal disorders and their connection to liver disease.
• To highlight areas for future research into peroxisome-MASLD interactions.

Main Methods:

• Literature review of peroxisomal disorders and MASLD.
• Analysis of molecular mechanisms linking peroxisomal function to liver health.
• Synthesis of evidence for peroxisomal involvement in MASLD development.

Main Results:

• Peroxisomal defects can lead to metabolic disturbances relevant to liver steatosis.
• Specific peroxisomal enzymes and biogenesis pathways are implicated in lipid metabolism.
• Evidence suggests a plausible connection between impaired peroxisomal function and MASLD pathogenesis.

Conclusions:

• Peroxisomal dysfunction represents a potential contributing factor to MASLD.
• Further research is warranted to elucidate the precise mechanisms linking peroxisomes and MASLD.
• Understanding this link may offer novel therapeutic targets for MASLD.